NVC-001
Asset
AAV gene therapy targeting mechanobiological pathways to rescue nuclear envelope strain in LMNA cardiomyopathy
- Stage
- Phase 1
- Modality
- Gene therapy
- Target
- LMNA
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1LMNA dilated cardiomyopathy
Phase 1, prnewswire.com, 8 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors1
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.